These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8221382)

  • 21. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis.
    Gieffers J; Pohl D; Treib J; Dittmann R; Stephan C; Klotz K; Hanefeld F; Solbach W; Haass A; Maass M
    Ann Neurol; 2001 May; 49(5):585-9. PubMed ID: 11357948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis.
    Melø TM; Larsen C; White LR; Aasly J; Sjøbakk TE; Flaten TP; Sonnewald U; Syversen T
    Biol Trace Elem Res; 2003; 93(1-3):1-8. PubMed ID: 12835484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide as an activity marker in multiple sclerosis.
    Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
    J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-CAM in cerebrospinal fluid: a marker of synaptic remodelling after acute phases of multiple sclerosis?
    Massaro AR; Albrechtsen M; Bock E
    Ital J Neurol Sci; 1987 Jun; Suppl 6():85-8. PubMed ID: 3654182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
    Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Chiarini P; Gallai V
    J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
    Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leukotrienes and neurological diseases].
    Irkeç C; Ercan S; Irkeç M
    Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
    Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
    Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Dong-Si T; Weber J; Liu YB; Buhmann C; Bauer H; Bendl C; Schnitzler P; Grond-Ginsbach C; Grau AJ
    J Neurol; 2004 May; 251(5):542-7. PubMed ID: 15164186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
    Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
    J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.
    Mattsson N; Haghighi S; Andersen O; Yao Y; Rosengren L; Blennow K; Praticò D; Zetterberg H
    Neurosci Lett; 2007 Mar; 414(3):233-6. PubMed ID: 17227694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
    Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
    Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases.
    Otto C; Kalantzis R; Kübler-Weller D; Kühn AA; Böld T; Regler A; Strathmeyer S; Wittmann J; Ruprecht K; Heelemann S
    J Neuroinflammation; 2024 Sep; 21(1):234. PubMed ID: 39327581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid in multiple sclerosis.
    Lowenthal A; Karcher D
    Clin Neurosci; 1994; 2(3-4):211-4. PubMed ID: 7749890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis.
    Aasly J; Gårseth M; Sonnewald U; Zwart JA; White LR; Unsgård G
    Acta Neurol Scand; 1997 Jan; 95(1):9-12. PubMed ID: 9048978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient.
    Commodari F; Arnold DL; Sanctuary BC; Shoubridge EA
    NMR Biomed; 1991 Aug; 4(4):192-200. PubMed ID: 1931558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High resolution NMR spectroscopy of CSF: methodological issues and perspective clinical applications].
    Kriat M; Nicoli F; Vion-Dury J; Confort-Gouny S; Dano P; Grisoli F; Gastaut JL; Cozzone PJ
    Ann Biol Clin (Paris); 1991; 49(9):461-7. PubMed ID: 1789500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
    Szalardy L; Zadori D; Tanczos E; Simu M; Bencsik K; Vecsei L; Klivenyi P
    Neurosci Lett; 2013 Oct; 554():131-4. PubMed ID: 24021801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic analysis of cerebral spinal fluid from patients with severe brain injury.
    Glenn TC; Hirt D; Mendez G; McArthur DL; Sturtevant R; Wolahan S; Fazlollahi F; Ordon M; Bilgin-Freiert A; Ellingson B; Vespa P; Hovda DA; Martin NA
    Acta Neurochir Suppl; 2013; 118():115-9. PubMed ID: 23564115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.